CANTOS Study Shows Reducing Inflammation Cuts Cardiovascular Disease, Lung Cancer Risk
News | ESC | September 12, 2017

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk...

COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies | September 12, 2017

September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with...

Orange County, Calif. Hospital Adopts Siemens Somatom Force CT for Cardiac Imaging
News | Computed Tomography (CT) | September 12, 2017

September 12, 2017 — Hoag Memorial Hospital Presbyterian recently became the first hospital in Orange County, Calif...

Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.

The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO).

Feature | Cath Lab | September 12, 2017

September 12, 2017 – The Cardiovascular Research Foundation (CRF)...

ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017

September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking...

Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab | September 11, 2017

September 11, 2017 — According to the latest market study released by Technavio, the global...

TCT 2017 late-breaking trials and studies that will be presented on the latest cardiology technology clinical trials.
Feature | September 11, 2017

September 11, 2017 — From numerous high-quality submissions, Transcatheter Cardiovascular Therapeutics (TCT) has...

Merck Announces Results of REVEAL Outcomes Study of Anacetrapib
News | Pharmaceuticals | September 11, 2017

September 11, 2017 — Merck and researchers in the Clinical Trial Service Unit at the University of Oxford announced...

Veniti Announces Boston Scientific Distribution Agreement for Vici Venous Stent
News | Venous Therapies | September 11, 2017

September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a...

Systolic Blood Pressure at Time of STEMI PCI May Predict In-Hospital Mortality
News | Cath Lab | September 11, 2017

September 11, 2017 — Researchers have led a retrospective single-center...

An example of advanced image guidance for complex EP and cath lab procedures.

An example of advanced visualization and image navigation technologies from Philips to improve accuracy, speed and enable more complex transcatheter procedures. 

Blog | Business | September 08, 2017

A cardiovascular service line manager reader of DAIC recently e-mailed me and asked if I had a list of the top...

ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017

September 8, 2017 — ClearFlow Inc. announced recently that positive...

Abbott will end sales of the Absorb bioresorbable stent scaffold, pulling it off the market September 14, 2017.
Feature | Stents Bioresorbable | September 08, 2017 | Dave Fornell

September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular...

Technology | Radiation Dose Management | September 07, 2017

September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to...

FDA Holds MIDAC Meeting on Gadolinium-Based Contrast Agents. Image by Marilyn Fornell
News | Contrast Media | September 07, 2017

September 7, 2017 — The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical...

Overlay Init